Clik here to view.
Avita Announces Receipt of $975K R&D Tax Incentive
VALENCIA, Calif. & PERTH, Australia & CAMBRIDGE, England Avita Medical Limited (ASX:AVH) (OTCQX:AVMXY), a regenerative medicine company focused on the treatment of wounds and skin defects,...
View ArticleClik here to view.
Chi-Med: Grant of Awards under Long Term Incentive Plan
LONDON Hutchison China MediTech Limited (“Chi-Med”) (AIM/Nasdaq: HCM) announces that on March 15, 2017, it granted conditional awards (“LTIP Awards”) under the Long Term Incentive Plan (“LTIP”)...
View ArticleClik here to view.
SpinalCyteの画期的な椎間板再生試験で初の線維芽細胞注入が実施される
ヒューストン （ビジネスワイヤ） — テキサスに拠点を置き、ヒト皮膚線維芽細胞を使用した椎間板髄核の再生に傾注する組織工学技術企業のSpinalCyte,...
View ArticleClik here to view.
Water Quality Testing Advances Ten Times the Current Standards with new...
MADISON, Wis. Rapid and reliable on-line measurement of water quality with sensitivity more than ten times current standards is now available to the water industry. Promega Corporation and AppliTek...
View ArticleClik here to view.
Ferring Pharmaceuticals：专家在世界睡眠日表示，起夜是夜眠差的头号原因
瑞士圣普雷 (美国商业资讯) — 在世界睡眠日，睡眠专家鼓励人们去了解健康酣睡的价值。尤其是30岁以上成人每3人中有1人、三分之二65岁以上成人的睡眠受夜尿症困扰，即夜醒排尿一次以上1。 马斯特里赫特大学泌尿科教授、夜尿症资源中心编辑Philip Van...
View ArticleClik here to view.
Notice of Establishment: New Company, Denka-KEW Genomics
CAMBRIDGE, Mass. Today, we announce that on February 15, 2017, KEW, Inc., a privately-held molecular diagnostics company located in Cambridge, MA, USA and Denka, Co., Ltd. , a commercial...
View ArticleClik here to view.
Novocure Receives MHLW Approval for Second Generation Optune® in Japan
ST. HELIER, Jersey Novocure (NASDAQ:NVCR) today announced that the Japanese Ministry of Health, Labour and Welfare (MHLW) has approved second generation Optune. Second generation Optune features a...
View ArticleClik here to view.
X-Chemが複数の治療領域でアステラス製薬との戦略的連携を発表
米マサチューセッツ州ウォルサム （ビジネスワイヤ） — 革新的な創薬能力を新規低分子医薬品の創出に適用している非上場バイオテクノロジー企業のX-Chem,...
View ArticleClik here to view.
SCIEX and the Children’s Medical Research Institute Announce Opening of...
FRAMINGHAM, Mass. & SYDNEY SCIEX, a global leader in life science analytical technologies, has announced that Children’s Medical Research Institute (CMRI) has opened ProCan™, the Australian...
View ArticleClik here to view.
ANK免疫細胞療法の治療経過を学会発表
東京 （ビジネスワイヤ） — 先進的ながん免疫細胞療法をサポートするリンパ球バンク株式会社（本社：東京都千代田区、代表取締役：藤井真則）が運営する細胞培養センターを利用し、ＡＮＫ免疫細胞療法を提供する医師が、細胞培養を実施する医師らと共同で、3月7日から10日に東京で開催された、「第18回 国際ヒトレトロウィルスＨＴＬＶ会議」で、ANK免疫細胞療法の治療経過を発表しました。 このSmart...
View ArticleClik here to view.
Alexion Submits Application in Japan for Soliris® (Eculizumab) as a Potential...
NEW HAVEN, Conn. Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) announced today that it has submitted an application to Japan’s Ministry of Labour and Welfare (MHLW) to extend the indication for...
View ArticleClik here to view.
Primary Health Care Limited (Primary) Signs Deal to Deploy Intelerad Medical...
MONTREAL Highlights: Primary operates 141 diagnostic imaging locations across Australia (public hospitals, private hospitals, medical centres and community-based centres) Intelerad’s medical imaging...
View ArticleClik here to view.
GI Dynamics to Release 2016 Annual Report and Host Webcast for Year Ending 31...
BOSTON & SYDNEY GI Dynamics, Inc. (ASX: GID), a medical device company that has commercialized EndoBarrier® in Europe and the Middle East for patients with type 2 diabetes and obesity, announced...
View ArticleClik here to view.
フェリング・ファーマシューティカルズ：夜中のトイレ起きは質の悪い睡眠の最大の原因であると専門家らが世界睡眠デーで指摘
スイス・サンプレ （ビジネスワイヤ） — 「世界睡眠デー」に当たり、睡眠の専門家らは人々に対し、健康で充実した睡眠の価値を理解するよう喚起しています。特に夜間に1回以上トイレに行く必要がある場合は夜間頻尿と見なされますが、30歳超の成人の3人に1人、65歳超の成人の3分の2がこの症状を患っています1。 「夜間頻尿リソースセンター」の編集者でマーストリヒト大学泌尿器科教授のPhilip Van...
View ArticleClik here to view.
Dr. Reddy’s and Integra LifeSciences Enter into an Agreement to Market and...
HYDERABAD, India Dr. Reddy’s Laboratories Limited (BSE:500124, NSE:DRREDDY, NYSE:RDY) and Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company,...
View ArticleClik here to view.
Clik here to view.
Takeda’s Dengue Vaccine Candidate Elicited Broad Immune Responses in Children...
OSAKA, Japan Takeda Pharmaceutical Company Limited [TSE: 4502], (“Takeda”) today announced that data from a 6-month interim analysis* of the ongoing DEN-204 trial of its live-attenuated tetravalent...
View ArticleClik here to view.
Ra Medical Systems Receives Approval in China for Pharos Dermatology Laser
CARLSBAD, Calif. Ra Medical Systems, Inc., makers of excimer lasers and catheters for cardiovascular and dermatological diseases, has received FDA (CFDA) approval for the Pharos Excimer Laser to...
View ArticleClik here to view.
IncellDx发布获得CE-IVD标记的定量单细胞PD-L1 OncoTect iO®检测
加州门罗帕克 (美国商业资讯) — IncellDx, Inc.于2017年3月30日发布获得CE标记的OncoTect iO®肺试剂盒，进军欧洲和其他接受CE标记的国家的免疫治疗诊断市场，该试剂盒符合用于体外诊断器械注册的欧洲体外诊断指导意见98/79 EC。OncoTect...
View ArticleClik here to view.
IncellDxがCE-IVD認証済みの単細胞PD-L1 OncoTect iO®定量的アッセイをリリース
米カリフォルニア州メンロパーク （ビジネスワイヤ） — IncellDx, Inc.は2017年3月30日の本日、CEマークを取得した当社のOncoTect iO® Lung Kitのリリースを発表し、欧州の免疫療法診断市場に加え、CEマークと、体外診断機器の登録のための欧州体外診断用医療機器指令98/79...
View Article